HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
thorium-4-benzyl-DOTA-rituximab
putative radioimmunotherapy agent for treating non-Hodgkin's lymphoma
Also Known As:
227Th-p-benzyl-DOTA-rituximab
Networked:
0
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Blood Proteins: 12459
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Murine-Derived Monoclonal Antibodies: 1
Rituximab: 15450
thorium-4-benzyl-DOTA-rituximab
Immunoproteins: 43
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Murine-Derived Monoclonal Antibodies: 1
Rituximab: 15450
thorium-4-benzyl-DOTA-rituximab
Globulins: 3062
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Murine-Derived Monoclonal Antibodies: 1
Rituximab: 15450
thorium-4-benzyl-DOTA-rituximab
Organic Chemicals: 133
Organometallic Compounds: 64
thorium-4-benzyl-DOTA-rituximab